Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colitis, Ulcerative 3Arthritis, Rheumatoid 3Spondylitis, Ankylosing 1Recurrence 1Prostatic Neoplasms 1Lymphoma 1Inflammatory Bowel Diseases 1Diabetes Mellitus, Type 1 1Crohn Disease 1

Interventions

Certolizumab Pegol 5Infliximab 4Adalimumab 3Nivolumab 2MEDI2070 2vedolizumab 1secukinumab 1golimumab 1cabozantinib 1Vitamin E 1Vaccines 1Ustekinumab 1Sutures 1Surgical Instruments 1Specimen Handling 1Soybean Oil 1Saline Solution 1Ringer's Lactate 1Pneumococcal Vaccines 1Platinum Compounds 1Photoplethysmography 1Papillomavirus Vaccines 1Methoxsalen 1Medical Marijuana 1Lysine Acetyltransferase 5 1Iron-Dextran Complex 1Ipilimumab 1Indigo Carmine 1Hydroxyethyl Starch Derivatives 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Crohn Disease × golimumab × Clear all
NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Janssen Scientific Affairs, LLC

Phase 4 Completed
1 enrolled 1 chart
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡